Although substantial progress has been made in the diagnosis and treatment of acute
coronary syndromes, cardiovascular disease remains the leading cause of death globally …

Acute coronary syndrome (ACS) describes the range of myocardial ischemic states that
includes unstable angina, non-ST elevated myocardial infarction (MI), or ST-elevated MI …

Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Acute coronary syndrome encompasses a broad and heterogeneous population that
challenges the clinician at each step of treatment in terms of: 1) diagnosis; 2) appropriate …

Background India has the highest burden of acute coronary syndromes in the world, yet little
is known about the treatments and outcomes of these diseases. We aimed to document the …

Modern management of acute myocardial infarction is built on a clinical evidence base
drawn from many studies undertaken over the past three decades. The evolution in clinical …

Clinicians have become increasingly sophisticated in their application of cardiac biomarkers
in the management of acute coronary syndromes (ACS). In the 1950s, clinical investigators …

The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …

Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …

Biomarkers complement clinical assessment and the 12-lead ECG in the diagnosis, risk
stratification, triage, and management of patients with suspected acute coronary syndrome …